Patents by Inventor Salah Kivlighn

Salah Kivlighn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for cardiovascular disease
    Patent number: 7799794
    Abstract: This invention relates to a method for treating and preventing hypertension by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment. Additionally, the scope of the invention includes a method of treating coronary heart disease by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: September 21, 2010
    Assignees: Merck Sharp & Dohme Corp., University of Washington
    Inventors: Salah Kivlighn, Richard Johnson, Marilda Mazzali
  • Treatment for Cardiovascular Disease
    Publication number: 20090130078
    Abstract: This invention relates to a method for treating and preventing hypertension by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment. Additionally, the scope of the invention includes a method of treating coronary heart disease by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment.
    Type: Application
    Filed: January 27, 2009
    Publication date: May 21, 2009
    Inventors: Salah Kivlighn, Richard J. Johnson, Marilda Mazzali
  • Treatment for Cardiovascular Disease
    Publication number: 20070232551
    Abstract: This invention relates to a method for treating and preventing hypertension by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment. Additionally, the scope of the invention includes a method of treating coronary heart disease by administering a therapeutically effective amount of an agent capable of reducing uric acid levels in a patient in need of such treatment.
    Type: Application
    Filed: April 4, 2007
    Publication date: October 4, 2007
    Inventors: Salah Kivlighn, Richard Johnson, Marilda Mazzali
  • Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
    Patent number: 5444067
    Abstract: This invention relates to compounds represented by formula I: ##STR1## which are agonists of angiotensin II. The invention is also concerned with the use of aforementioned agonists in the treatment of states meditated by angiotensin.
    Type: Grant
    Filed: August 30, 1993
    Date of Patent: August 22, 1995
    Assignee: Merck & Co., Inc.
    Inventors: Salah Kivlighn, Victor J. Lotti, Ralph A. Rivero, Peter K. S. Siegl, Gloria J. Zingaro